Julie emphasizes taking the field seriously as medicine, not "industry," building partnerships with pharmaceutical companies, and forging alliances with physician colleagues who value collaborative care
There was also a trend on weight change: 32 mg resulting in 6.1% weight loss
On May 13, at the 33rd European Congress on Obesity in Istanbul, Trkiye, findings from the Phase III SURMOUNT-MAINTAIN trial (NCT06047548) were presented, evaluating the use of Eli Lilly's Zepbound (tirzepatide) in sustaining weight loss following an initial 60-week open-label weight-loss period
Storage and handling for tirzepatide niacinamide Proper storage is essential to maintain peptide stability and efficacy
If you're experiencing drenching sweats that disrupt your sleep, Doctronic can help identify the underlying cause and appropriate treatment options